ATF4 promotes immune evasion in oral squamous cell carcinoma by suppressing autophagic PD-L1 degradation
Background
Immune checkpoint blockade targeting programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) has revolutionized cancer therapy. However, its efficacy is frequently limited by primary and acquired resistance. While inflammatory signals tra…